[ad_1]
During negotiations between the European Commission and Novavax, the Cabinet of Ministers on February 3. Approved 620 thousand. for the purchase of vaccine doses from this manufacturer, but after the proportional distribution of quantities among the Member States of the European Union (EU), Lithuania received a little more than 616 thousand doses of vaccine.
Some Member States wanted to buy fewer vaccines than were offered in accordance with the principle of proportionality, and additional vaccines were offered to the other countries.
The government agreed to purchase them based on an advance delivery program, simple transportation and storage conditions, and protection against the South African COVID-19 mutation.
Currently, the vaccines from three manufacturers are registered and used in the European Union: BioNTech & Pfizer, Moderna and AstraZeneca. Advance agreements have also been entered into with pharmaceutical companies Janssen Pharmaceutica NV, Sanofi Pasteur & GSK and CureVac. The European Commission is also negotiating with Novavax and Valneva.
According to the preliminary agreements already concluded, Lithuania has obtained more than 9 million. dose of vaccine. This amount should be enough to vaccinate more than 70 percent. population of the country. According to experts, such a proportion of the vaccinated population would guarantee herd immunity against the coronavirus.
It is strictly prohibited to use the information published by DELFI on other websites, in the media or elsewhere, or to distribute our material in any way without consent, and if consent has been obtained, it is necessary to indicate DELFI as the source. .
[ad_2]
